Pregnancy and Pulmonary Hypertension

Clinics in Chest Medicine

Volumn 32, Issue 1, 2011, Pages 165-174

  Lane, C Randall ^a   Trow, Terence K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Conception counseling; Management; Pregnancy; Pulmonary hypertension

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; FONDAPARINUX; HEPARIN; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; PROSTANOID; SILDENAFIL; TADALAFIL; UNIPROST; VASODILATOR AGENT;

AMNION FLUID EMBOLISM; ANESTHESIOLOGICAL TECHNIQUES; CONCEPTION; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; HEART CATHETERIZATION; HUMAN; LUNG VASCULAR RESISTANCE; MATERNAL MORTALITY; NONHUMAN; PATIENT COUNSELING; PATIENT MONITORING; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRENATAL SCREENING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; THROMBOCYTOPENIA; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT PLANNING; VENOUS THROMBOEMBOLISM;

DELIVERY, OBSTETRIC; DIRECTIVE COUNSELING; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MATERNAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 79251508000     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2010.10.006     Document Type: Review

References (67)

1. Mccaffrey R., Dunn L. Primary pulmonary hypertension in pregnancy. Obstet Gynecol Surv 1964, 19:567.
2. Madden B. Pulmonary hypertension and pregnancy. Int J Obstet Anesth 2009, 18:156.
3. Warnes C. Pregnancy and pulmonary hypertension. Int J Cardiol 2004, 97(Suppl 1):11.
4. Marik P., Plante L. Venous thromboembolic disease and pregnancy. N Engl J Med 2008, 359:2025.
5. Badesch D., Raskob G., Elliott C., et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010, 137:376.
6. Simonneau G., Robbins I., Beghetti M., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43.
7. Arcasoy S., Christie J., Ferrari V., et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003, 167:735.
8. Penning S., Robinson K., Major C., et al. A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol 2001, 184:1568.
9. Wylie B., Epps K., Gaddipati S., et al. Correlation of transthoracic echocardiography and right heart catheterization in pregnancy. J Perinat Med 2007, 35:497.
10. Chakravarty E., Khanna D., Chung L. Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol 2008, 111:927.
11. Weiss B., Zemp L., Seifert B., et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998, 31:1650.
12. Bédard E., Dimopoulos K., Gatzoulis M. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?. Eur Heart J 2009, 30:256.
13. Smedstad K., Cramb R., Morison D. Pulmonary hypertension and pregnancy: a series of eight cases. Can J Anaesth 1994, 41:502.
14. Bonnin M., Mercier F., Sitbon O., et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005, 102:1133.
15. Zwicke D.L., Buggy B.P. Pregnancy and pulmonary arterial hypertension: successful management of 37 consecutive patients [abstract]. Chest 2008, 134. 64002S.
16. Tahir H. Pulmonary hypertension, cardiac disease and pregnancy. Int J Gynaecol Obstet 1995, 51:109.
17. Trow T., McArdle J. Diagnosis of pulmonary arterial hypertension. Clin Chest Med 2007, 28:59.
18. Siva A., Shah A. Moderate mitral stenosis in pregnancy: the haemodynamic impact of diuresis. Heart 2005, 91:e3.
19. Bonow R., Carabello B., Chatterjee K., et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:e1.
20. de Souza J., Martinez E.J., Ambrose J., et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. J Am Coll Cardiol 2001, 37:900.
21. Sivadasanpillai H., Srinivasan A., Sivasubramoniam S., et al. Long-term outcome of patients undergoing balloon mitral valvotomy in pregnancy. Am J Cardiol 2005, 95:1504.
22. Kelly M., Rustin G., Ivory C., et al. Respiratory failure due to choriocarcinoma: a study of 103 dyspneic patients. Gynecol Oncol 1990, 38:149.
23. Seckl M., Rustin G., Newlands E., et al. Pulmonary embolism, pulmonary hypertension, and choriocarcinoma. Lancet 1991, 338:1313.
24. Gangadharan V., Chitrathara K., Sivaramakrishnan R., et al. Pulmonary hypertension-a rare presentation of choriocarcinoma. Acta Oncol 1993, 32:461.
25. Conde-Agudelo A., Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol 2009, 201:445. e1.
26. Khong T. Expression of endothelin-1 in amniotic fluid embolism and possible pathophysiological mechanism. Br J Obstet Gynaecol 1998, 105:802.
27. McDonnell N., Chan B., Frengley R. Rapid reversal of critical haemodynamic compromise with nitric oxide in a parturient with amniotic fluid embolism. Int J Obstet Anesth 2007, 16:269.
28. O'Shea A., Eappen S. Amniotic fluid embolism. Int Anesthesiol Clin 2007, 45:17.
29. Van Heerden P., Webb S., Hee G., et al. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia. Anaesth Intensive Care 1996, 24:87.
30. Galiè N., Seeger W., Naeije R., et al. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2004, 43:81S.
31. Thorne S., Nelson-Piercy C., MacGregor A., et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care 2006, 32:75.
32. Temelcos C., Kuhn R., Stribley C. Sterilization of women with Eisenmenger syndrome: report of 4 cases. Aust N Z J Obstet Gynaecol 1997, 37:121.
33. Weiss B., Hess O. Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 2000, 21:104.
34. Robinson J., Banerjee R., Landzberg M., et al. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension. Am J Obstet Gynecol 1999, 180:1045.
35. Weiss B., Maggiorini M., Jenni R., et al. Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology 2000, 92:1191.
36. Toyama H., Wagatsuma T., Ejima Y., et al. Cesarean section and primary pulmonary hypertension: the role of intravenous dexmedetomidine. Int J Obstet Anesth 2009, 18:262.
37. Abboud T., Raya J., Noueihed R., et al. Intrathecal morphine for relief of labor pain in a parturient with severe pulmonary hypertension. Anesthesiology 1983, 59:477.
38. Martin J., Tautz T., Antognini J. Safety of regional anesthesia in Eisenmenger's syndrome. Reg Anesth Pain Med 2002, 27:509.
39. Johnstone M. The cardiovascular effects of oxytocic drugs. Br J Anaesth 1972, 44:826.
40. Roberts N., Keast P., Brodeky V., et al. The effects of oxytocin on the pulmonary and systemic circulation in pregnant ewes. Anaesth Intensive Care 1992, 20:199.
41. Price L., Forrest P., Sodhi V., et al. Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 2007, 99:552.
42. Stewart R., Tuazon D., Olson G., et al. Pregnancy and primary pulmonary hypertension: successful outcome with epoprostenol therapy. Chest 2001, 119:973.
43. Rietema H., Holverda S., Bogaard H., et al. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur Respir J 2008, 31:759.
44. Stolz D., Rasch H., Linka A., et al. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J 2008, 32:619.
45. Badesch D., Tapson V., McGoon M., et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000, 132:425.
46. Barst R., Rubin L., McGoon M., et al. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994, 121:409.
47. Rubin L., Mendoza J., Hood M., et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Intern Med 1990, 112:485.
48. Bendayan D., Hod M., Oron G., et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol 2005, 106:1206.
49. Bildirici I., Shumway J. Intravenous and inhaled epoprostenol for primary pulmonary hypertension during pregnancy and delivery. Obstet Gynecol 2004, 103:1102.
50. Easterling T., Ralph D., Schmucker B. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol 1999, 93:494.
51. Lacassie H., Germain A., Valdés G., et al. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol 2004, 103:1118.
52. Lam G., Stafford R., Thorp J., et al. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol 2001, 98:895.
53. Lust K., Boots R., Dooris M., et al. Management of labor in Eisenmenger syndrome with inhaled nitric oxide. Am J Obstet Gynecol 1999, 181:419.
54. Parisi V., Walsh S. Fetal vascular responses to prostacyclin. Am J Obstet Gynecol 1989, 160:871.
55. Molelekwa V., Akhter P., McKenna P., et al. Eisenmenger's syndrome in a 27 week pregnancy-management with bosentan and sildenafil. Ir Med J 2005, 98:87.
56. Goland S., Tsai F., Habib M., et al. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension. Cardiology 2010, 115:205.
57. Samangaya R., Mires G., Shennan A., et al. A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia. Hypertens Pregnancy 2009, 28:369.
58. Barst R., Gibbs J., Ghofrani H., et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54:S78.
59. Frank H., Mlczoch J., Huber K., et al. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest 1997, 112:714.
60. Fuster V., Steele P., Edwards W., et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984, 70:580.
61. Rich S., Kaufmann E., Levy P. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992, 327:76.
62. Pitts J., Crosby W., Basta L. Eisenmenger's syndrome in pregnancy: does heparin prophylaxis improve the maternal mortality rate?. Am Heart J 1977, 93:321.
63. Oakley C. Anticoagulation and pregnancy. Eur Heart J 1995, 16:1317.
64. Greer I., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005, 106:401.
65. Carlin A., Farquharson R., Quenby S., et al. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control. Hum Reprod 2004, 19:1211.
66. Pettilä V., Leinonen P., Markkola A., et al. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002, 87:182.
67. Mazzolai L., Hohlfeld P., Spertini F., et al. Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood 2006, 108:1569.